C. auris, first identified in 2009 in Asia, has quickly become a cause of severe infections around the world. C. auris is a concerning drug-resistant fungus. It can cause outbreak in healthcare fa...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
Era Biology at ECCMID 2023, Denmark
Era Biology, a leader and pioneer of invasive fungal disease (IFD) diagnostics field, has exhibited at the European Congress of Clinical Microbiology and Infecti...
A few days ago, ERA BIO (Suzhou) New Product Launch Conference and Liandong U Valley Signing Ceremony was successfully completed in Suzhou, Jiangsu! At this press conference, Yirui Biological rele...
Era Biology will host a global live webinar on November 29th 2022 22:00 (GMT +08:00). The webinar will talk about complete solutions for aspergillus galactomannan tests.
Aspergillus is often not sp...
On May 14th, Era Biology will hold the online seminar for diagnosis and treatment of infectious disease. The professors from hospital in Jiangsu province and Anhui province are invited to attend th...